Type 2 diabetes

Our product line for Type 2 Diabetes (T2D) research provides a comprehensive suite of human primary cells and specialized extracellular matrix (ECM) hydrogels tailored for modeling metabolic dysfunction and insulin resistance. Sourced from both healthy and T2D donors, our portfolio includes adipocytes, preadipocytes, hepatocytes, myocytes, and endothelial cells, enabling precise recreation of the complex tissue interactions involved in glucose metabolism and energy homeostasi